HealthInvest Partners AB as of June 30, 2022
Portfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 12 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Utah Medical Products (UTMD) | 17.0 | $7.4M | 86k | 85.90 | |
| La Jolla Pharmaceuticl Com Par | 9.3 | $4.0M | 1.3M | 3.19 | |
| Harmony Biosciences Hldgs In (HRMY) | 8.5 | $3.7M | 76k | 48.78 | |
| Cigna Corp (CI) | 8.5 | $3.7M | 14k | 263.50 | |
| Gilead Sciences (GILD) | 8.3 | $3.6M | 58k | 61.81 | |
| Bristol Myers Squibb (BMY) | 7.8 | $3.4M | 44k | 77.00 | |
| Biogen Idec (BIIB) | 7.5 | $3.3M | 16k | 203.94 | |
| McKesson Corporation (MCK) | 7.5 | $3.3M | 10k | 326.20 | |
| Viatris (VTRS) | 7.5 | $3.2M | 310k | 10.47 | |
| Kempharm Com New (ZVRA) | 6.9 | $3.0M | 670k | 4.46 | |
| Opiant Pharmaceuticals | 5.8 | $2.5M | 210k | 11.99 | |
| Aurinia Pharmaceuticals (AUPH) | 5.3 | $2.3M | 230k | 10.05 |
